Ibuprofen Lysine is used for closing a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g. It was first introduced by Recordati Rare Diseases Inc in its drug Neoprofen on Apr 13, 2006. 2 different companies have introduced drugs containing Ibuprofen Lysine.

Ibuprofen Lysine Patents

Given below is the list of patents protecting Ibuprofen Lysine, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Neoprofen	US8415337	Ibuprofen compositions and methods of making same	Mar 02, 2032	Recordati Rare
Neoprofen	US6344479	Method of preventing retinopathy of prematurity in a neonate	Mar 20, 2021 (Expired)	Recordati Rare
Neoprofen	US6342530	Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt	Nov 14, 2020 (Expired)	Recordati Rare

Add above patents to watchlist

Ibuprofen Lysine's Family Patents

Unlock Global Patents

Ibuprofen Lysine Generic API Manufacturers

Only one generic application has been filed for Ibuprofen Lysine.

Given below is the list of companies who have filed for Ibuprofen Lysine generic, along with the locations of their manufacturing plants worldwide.